Khosla Ventures

Khosla Ventures is a Palo Alto–headquartered venture capital firm founded by Vinod Khosla that manages roughly $15–16 billion in assets...

Facts

HQ
United States
Sectors
Venture Capital, Investing

Scaled Foundations Launches AI Platform GRID to Enable Natural Language Programming of Robots, Backed by Khosla Ventures and E14

Scaled Foundations, a Seattle-based startup led by former Microsoft executive Ashish Kapoor, has launched an AI-powered platform called GRID to simplify programming robots through natural language prompts. Backed by Khosla Ventures and E14, the platform enables non-technical users to command robots like drones for complex tasks by integrating AI models and simulations.

Viome raises $86.5M Series C and partners with CVS to sell $179 at-home Full Body Intelligence gut test in 200 stores

Seattle-area health tech startup Viome Life Sciences raised an $86.5 million Series C and struck a deal to sell its $179 at-home Full Body Intelligence gut microbiome test in 200 CVS stores and online. Founded by Naveen Jain, Viome analyzes stool, saliva and blood samples and counts investors including Marc Benioff and Khosla Ventures, though some scientists question clinical utility of microbiome kits.

Oddity Tech (Il Makiage, SpoiledChild) raises $424M in Nasdaq IPO at $35 a share; opens at $49.10, $2.8B market cap

Oddity Tech, the Israeli parent of Il Makiage and SpoiledChild, postponed a planned 2022 IPO and went public on Nasdaq under ticker ODD after strong financial gains; net income rose to $19.6 million for the year ending March 2023, up 553% year-over-year. The company raised nearly $424 million selling shares at $35, opened at $49.10 giving a $2.8 billion market cap, and reported SpoiledChild reached $100 million revenue in under a year.

Viome Life Sciences raises $67M Series C to expand at-home gut, immune and cancer screening tests

Bellevue-based Viome Life Sciences raised over $67 million in Series C funding to expand its at-home health screening test business, bringing total capital raised to more than $150 million. Founder and CEO Naveen Jain said the company plans to grow headcount from about 150 to ~200 and will hire more scientists, researchers, and engineers while keeping lab and supplement manufacturing automated.

David Baker Launches London Biotech Charm Therapeutics with $50M Series A to Advance Deep Learning Drug Discovery

David Baker, leader of the University of Washington Institute for Protein Design, co-founded London-based Charm Therapeutics, which uses deep learning to discover new small molecule therapeutics, and recently secured $50 million in Series A funding. The company's DragonFold platform predicts protein-small molecule interactions to aid drug discovery in cancer and other diseases.

Seashell raises $6M seed; Khosla, Kindred, Mark Cuban, Vlad Tenev and Coinbase Ventures back Seattle fintech offering up to 10% yields

Seashell, a 15-person Seattle fintech founded by Daryl Hok, raised $6 million in a seed round led by Khosla Ventures and Kindred Ventures with investors including Mark Cuban, Robinhood CEO Vlad Tenev and Coinbase Ventures; the startup offers up to 10% interest by investing user cash in gold and dollar-pegged digital assets but is not FDIC-insured and carries loss risk.

Coda raises $80M Series C led by Kleiner Perkins; Madrona and others join to scale document-as-app platform

Coda, a Bay Area startup led by ex-Microsoft and Google director Shishir Mehrotra, raised an $80 million Series C led by Kleiner Perkins with participation from Madrona Venture Group and others to expand its document-as-app collaboration platform used by companies like Spotify and Uber. Madrona said the investment aligns with its focus on Future of Work and low-code/no-code tools as remote work increases demand for collaboration software.

Opentrons launches OT-2 lab robot and no-code Protocol Designer after $10M seed round led by Khosla Ventures

Opentrons announced the launch of its OT-2 lab robot and a no-code Protocol Designer, backed by a $10 million seed round led by Khosla Ventures with participation from Lerer Hippeau, YC Continuity, and Jeff Kindler. The company says the product and funding support its goal to make affordable, customizable lab automation accessible to biologists and accelerate scientific discovery.

People

Online